Reprint
Peptides for Health Benefits 2019
Volume 2
Edited by
June 2020
340 pages
- ISBN978-3-03936-084-0 (Hardback)
- ISBN978-3-03936-085-7 (PDF)
This book is a reprint of the Special Issue Peptides for Health Benefits 2019 that was published in
This book is part of the book set Peptides for Health Benefits 2019
Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology
Summary
In recent years, peptides have received increased interest from the pharmaceutical industry. The high potency, specificity, and safety profile are the main strengths of bioactive peptides as new and promising therapies that may fill the gap between small molecules and protein drugs. These positive attributes have renewed interest in the discovery, optimization, and development of peptides as pharmacological therapy. Among bioactive peptides, those released from food sources have acquired importance as nutraceutical and active components in functional foods because they possess regulatory functions that can lead to health benefits. This Special Issue covers a selection of recent research papers and reviews in the field of bioactive peptides. It covers all aspects of peptide research in relation to health promotion. In particular, it emphasizes current knowledge and research trends concerning bioactive peptides, including identification and quantification of peptides from new sources, methods for their production and purification, structure–function relationships, mechanisms of action, in vitro and in vivo assays for the evaluation of their bioactivity, physiological evidence to support health benefits, and peptide stability and bioavailability. Papers regarding the development of new drugs, functional foods, or nutraceuticals based on bioactive peptides were also considered.
Format
- Hardback
License
© 2020 by the authors; CC BY-NC-ND license
Keywords
antihypertensive peptides; functional food; food-derived; fermentation; Chlorella sorokiniana; in silico; BIOPEP-UWM database; proteomics; bioactive peptides; nano liquid chromatography tandem mass spectrometry (nanoLC–nanoESI MS/MS); apolipoprotein E; amyloid fibrils; Alzheimer’s disease; Αβ oligomer; amyloid; Aβ peptide; glioma; platelets; antiproliferative assay; conjugation; docetaxel; doxorubicin; extra domain B; fibronectin; Fmoc/tBu; peptide–drug conjugate; prostate cancer; solid-phase synthesis; targeting; acrylamide; enteric nervous system; galanin; pig; stomach; formyl peptide receptors; ligands; diseases; polymicrobial biofilms; intragenic antimicrobial peptide; Hs02; Pseudomonas aeruginosa; Staphylococcus aureus; osteostatin; arthritis; inflammation; immune response; cartilage destruction; bone erosion; collagen; hydrolysis; enzyme; molecular weight; sheepskin; bioactive peptides; inflammation; NF-κB; dry-cured pork ham; angiotensin I converting enzyme; endothelial dysfunction; molecular blind docking; Lactoferricin B (Lfcin B); Histatin-5; antimicrobial peptides (AMPs); antifungal activity; proteome microarray; synergy; temporin; MRSA; antimicrobial peptide; human keratinocytes; pseudin-2; antimicrobial peptide; antisepsis, peptide antibiotics; neurotensin; asthma; inflammation; T cells; In situ tetramer staining; MHC tetramer; immune response; antigen-specific; confocal microscopy; fresh tissue; velvet antler; alcalase hydrolysate; antioxidant peptide; protection ability; oxidative stress; Crassostrea angulata; in silico; BIOPEP-UWM database; bioactive peptides; proteomics; pidotimod; CXCR3; monocyte; migration; PI3K/Akt pathway; T cell; immunomodulant; host defense peptides; membrane activity; copper; piscidins; Clostridioides difficile; prolactin-releasing peptide; GPR10; RF-amide peptides; food intake regulation; energy expenditure; neuroprotection; signaling; gender differences; dyslipidemia; obesity; hyperglycemia; pulmonary emphysema; endothelial progenitor cells; angiogenic precursor cells; pegylated glucagon-like peptide 1; and endothelial regeneration; miiuy croaker (Miichthys miiuy); swim bladder; FPYLRH; antioxidant activity; cytoprotective effect; antimicrobial peptides; antimicrobial resistance; AMP identification and design; biosynthesis; mode of action; physico-chemical properties; therapeutic potential; antimicrobial peptides; insects; Cecropins; Cec-analogs; MDR infectious diseases; airway inflammation; non-atopic asthma; hybrid peptide; pro-inflammatory cytokines; sPLA2; MDA; NF-κB; bioactive peptides; database; proteolysis; SMILES code; foods; nutrition; chronic diseases; nutraceuticals; peptide vaccine; immune checkpoint inhibitor; humanized mouse; cancer antigen; immune suppression; vasoactive intestinal peptide; VPAC1 receptor; VPAC2 receptor; rheumatic diseases; inflammatory bowel disease; central nervous system diseases; type 1 diabetes; Sjögren’s syndrome; biomarkers; host defense peptides; human antimicrobial peptides; defensins; cathelicidins; inflammation; anti-inflammatory; pro-inflammatory; peptide; combinatorial library; library design; screening; mutagenesis; prolyl-hydroxyproline (Pro-Hyp); hydroxyprolyl-glycine (Hyp-Gly); collagen peptide; fibroblasts; fetal bovine serum (FBS); AMD; CNV; VEGFR1; multimeric peptides; oral delivery; colorectal cancer; cancer stem cells; chemoprevention; bioactive peptide; lunasin; ACE-inhibitory activity; whey peptides; molecular docking; hypertension; antibiotic resistance; cystic fibrosis; antimicrobial peptides; host defense peptides; cryptides; anti-biofilm peptides; synergistic effects; n/a